CHOLAFIN(Cholamandalam Investment and Finance Company Limited)
02.11.2022 - CLSA on Cholafin Maintain Outperform CMP 742.75 Target 820
02.11.2022 - MS on Cholafin Maintain Equal-Weight CMP 742.75 Target 725
30.08.2022 - JpMorgan on Cholafin Maintain Underweight CMP 790.1 Target 600
01.08.2022 - MS on Cholafin Maintain Equal-Weight CMP 731.9 Target 725
08.04.2022 - Jefferies on Cholafin Maintain Buy CMP 686.75 Target 820
06.04.2022 - CITI on CHOLAFIN Maintain Neutral CMP 703 Target 740
29.03.2022 - CLSA on CHOLAFIN Maintain Outperform CMP 727 Target 825
18.01.2022 - MS On Chola Fin Maintain Overweight CMP 601 Target 710
MS ON CHOLA FIN : 03.08.2021
* Morgan Stanley maintains OVERWEIGHT call on Chola Fin, target at Rs 625/sh
* Confident In Managing Down Stage 2 + 3 Loans To Q4
* Co Plans Keeping Credit Costs At F21 levels
* Cut Forecasts To Account For Lower Loan Growth & Higher Provisioning
* MAINTAIN OVERWEIGHT TARGET: 625
We(rupeedesk.in) are SEBI Registered leading Indian Stock Market Trading Tips Providers for Equity,Commodity and currency market traded in NSE,BSE,MCX,NCDEX And MCXSX.USDINR,EURINR,GBPINR,JPYINR,Dollar,Euro,Pound,Yen currencies.Indian Currency futures and Options Trading Tips. . Free Currency Tips|Stock and Nifty Options Tips| Commodity Tips |Intraday Tips Register Here : 91-9094047040 |91-9841986753|044-24333577
Tuesday, February 22, 2022
CHOLAFIN
ERIS
ERIS(Eris Lifesciences Ltd) 18.01.2023 - Macquarie on ERIS Maintain Outperform CMP 625.75 Target 830